News

ILiAD Biotechnologies and hVIVO will collaborate on a Phase 3 human challenge trial for ILiAD’s next-generation intranasal pertussis vaccine,...

RenovoRx announced promising pharmacokinetic data from a sub-study of its ongoing Phase III TIGeR-PaC clinical trial, investigating its Trans-Arterial...

Cartesian Therapeutics (NASDAQ: RNAC) received FDA approval under the Special Protocol Assessment (SPA) process for the Phase 3 AURORA...

Adagene Inc. announced positive updated clinical data for ADG126 (muzastotug), an anti-CTLA-4 SAFEbody® drug, combined with pembrolizumab in a...

Novotech, a full-service international contract research organization (CRO), released a white paper analyzing global clinical trial trends in oncolytic...

Allurion Technologies, a company focused on obesity treatment, announced a registered direct offering of 1,240,000 shares of common stock...

Merck and Eisai announced results from the Phase 3 LEAP-015 trial, which examined the efficacy of Keytruda plus Lenvima...

Exelixis announced positive results from a subgroup analysis of the phase 3 CABINET study, showing cabozantinib improved progression-free survival...

Median Technologies secured a non-binding term sheet with the European Investment Bank (EIB) for a loan of up to...